Mar 04, 2021 / 12:30PM GMT
Sijmen de Vries - Pharming Group N.V. - Executive Director & CEO
Good afternoon, ladies and gentlemen, and welcome to the full year results conference call -- full year results 2020 conference call.
Before I go into this, I would like to point you to the slide that says forward-looking statements as this presentation may contain some forward-looking statements, including statements about our beliefs and expectations that are based on our current plans, estimates and projections, as well as our expectations of external conditions and events.
And after doing this, I would like to have the honor to introduce my new colleague, Jeroen Wakkerman, our new CFO, who joined us from, what is it, 16th of November. So he's very fresh still to the company, and who's sitting here next to me. And I'm very pleased Jeroen joined us. And I would like to hand over to you, Jeroen, to provide us with the financial highlights.
Jeroen Wakkerman - Pharming Group N.V. - CFO
Yes. Thank you very much, Sijmen. Maybe first a bit about why I joined Pharming at this
Q4 2020 Pharming Group NV Earnings Call Transcript
Mar 04, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers